<?xml version="1.0" encoding="UTF-8"?>
<p>We next performed the infectivity assay of mutant viruses with 100 Î¼M EGCG treatment during the whole infective process. The titers of mutant viruses were detected at 72 hpi and the results showed that EGCG could inhibit the infectivity of PCV2 (G54A) and PCV2 (N75A) (
 <xref ref-type="fig" rid="viruses-12-00176-f007">Figure 7</xref>f,h), similar to its antiviral effect on PCV2 (WT) and PCV2 (A135A) (
 <xref ref-type="fig" rid="viruses-12-00176-f007">Figure 7</xref>d,e). In contrast, the antiviral effect of EGCG could not be detected during the infection of PCV2 (D70A) and PCV2 (D78A) (
 <xref ref-type="fig" rid="viruses-12-00176-f007">Figure 7</xref>g,i), These findings are consistent with the results of affinity determinations (
 <xref ref-type="fig" rid="viruses-12-00176-f006">Figure 6</xref>c,f,g), indicating that ASP70 and ASP78 of capsid are essential for binding of PCV virions to EGCG.
</p>
